Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank17
Studio
Year-over-Year Change

Return on equity

Percentile
P17
Within normal range
vs 5Y Ago
-1.4x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025-57.01%-27.2%
2024-44.81%+36.7%
2023-70.79%-43.6%
2022-49.29%-43.5%
2021-34.35%-181.4%
202042.18%-16.2%
201950.32%-